David Cornblath

Professor

1973 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where David Cornblath is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 8 Similar Profiles
Chronic Inflammatory Demyelinating Polyradiculoneuropathy Medicine & Life Sciences
Peripheral Nervous System Diseases Medicine & Life Sciences
Guillain-Barre Syndrome Medicine & Life Sciences
Polyneuropathies Medicine & Life Sciences
Intravenous Immunoglobulins Medicine & Life Sciences
Neural Conduction Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Diabetic Neuropathies Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1973 2019

Chemotherapy-induced peripheral neurotoxicity: Facts, needs and future directions

Cavaletti, G. & Cornblath, D. R., Oct 1 2019, In : Journal of the Peripheral Nervous System. 24, S2, p. S86-S87

Research output: Contribution to journalEditorial

Drug Therapy
Direction compound

Current treatment practice of Guillain-Barré syndrome

IGOS Consortium, Jul 2 2019, In : Neurology. 93, 1, p. e59-e76

Research output: Contribution to journalArticle

Miller Fisher Syndrome
Therapeutics
Plasma Exchange
Intravenous Immunoglobulins
Bangladesh

Diagnosis and management of Guillain–Barré syndrome in ten steps

Leonhard, S. E., Mandarakas, M. R., Gondim, F. A. A., Bateman, K., Ferreira, M. L. B., Cornblath, D. R., van Doorn, P. A., Dourado, M. E., Hughes, R. A. C., Islam, B., Kusunoki, S., Pardo, C. A., Reisin, R., Sejvar, J. J., Shahrizaila, N., Soares, C., Umapathi, T., Wang, Y., Yiu, E. M., Willison, H. J. & 1 others, Jacobs, B. C., Nov 1 2019, In : Nature Reviews Neurology. 15, 11, p. 671-683 13 p.

Research output: Contribution to journalArticle

Guidelines
Disease Outbreaks
Polynesia
Latin America
Immune System Diseases

Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies

on Behalf of the PRIMA Trial Investigators and the PATH Study Group, Mar 1 2019, In : Journal of the Peripheral Nervous System. 24, 1, p. 48-55 8 p.

Research output: Contribution to journalArticle

Open Access
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Polyneuropathies
Intravenous Immunoglobulins
Safety
Drug-Related Side Effects and Adverse Reactions

Long-term safety and efficacy of subcutaneous immunoglobulin IgPro20 in CIDP: PATH extension study

Van Schaik, I. N., Mielke, O., Bril, V., Van Geloven, N., Hartung, H. P., Lewis, R. A., Sobue, G., Lawo, J. P., Praus, M., Durn, B. L., Cornblath, D. R. & Merkies, I. S. J., Sep 1 2019, In : Neurology: Neuroimmunology and NeuroInflammation. 6, 5

Research output: Contribution to journalArticle

Open Access
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Immunoglobulins
Safety
Recurrence
Hizentra